Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease

Von Hippel–Lindau (VHL), is a rare autosomal dominant inherited cancer in which the lack of VHL protein triggers the development of multisystemic tumors such us retinal hemangioblastomas (HB), CNS-HB, and clear cell renal cell carcinoma (ccRCC). ccRCC ranks third in terms of incidence and first in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Albiñana, Virginia, Gallardo-Vara, Eunate, de Rojas-P, Isabel, Recio-Poveda, Lucia, Aguado, Tania, Canto-Cano, Ana, Aguirre, Daniel T., Serra, Marcelo M., González-Peramato, Pilar, Martínez-Piñeiro, Luis, Cuesta, Angel M., Botella, Luisa Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563408/
https://www.ncbi.nlm.nih.gov/pubmed/32854260
http://dx.doi.org/10.3390/jcm9092740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563408/
https://www.ncbi.nlm.nih.gov/pubmed/32854260
http://dx.doi.org/10.3390/jcm9092740

Ejemplares similares